/PRNewswire/ Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) system™, Swoop®, today announced the appointment of.
/PRNewswire/ Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) system™, Swoop®, today announced the appointment of.
Don't panic over the Delta variant, especially about kids latimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latimes.com Daily Mail and Mail on Sunday newspapers.
Hoag to Participate in Groundbreaking Study Aiming to Help Prevent Memory Loss Due to Alzheimer s Disease
News provided by
Share this article
Share this article
NEWPORT BEACH, Calif., June 3, 2021 /PRNewswire/ Hoag s Pickup Family Neurosciences Institute has started recruiting volunteers for a study testing an investigational treatment that aims to help prevent the earliest stages of memory loss due to Alzheimer s disease.
Funded by the National Institutes of Health (NIH) and Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo), the AHEAD Study is the first Alzheimer s disease research study to recruit people as young as 55 years old who are at risk of developing symptoms of Alzheimer s disease as they get older. It introduces a personalized approach that will tailor treatment dosing levels to a participant s particular risk of memory loss related to Alzheimer s disease.